Edoxaban versus Warfarin in patients with atrial fibrillation

被引：0
|
作者：
Meras Colunga, P. [1 ]
机构：
[1] Hosp Univ La Paz, Serv Cardiol, Madrid, Spain
来源：
REVISTA CLINICA ESPANOLA | 2014年 / 214卷 / 06期
关键词：
D O I：
10.1016/j.rce.2014.02.017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：346 / 346
页数：1
相关论文
共 50 条
  • [21] Edoxaban vs warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
    Lip, G. Y. H.
    Al-Saady, N.
    Hjortshoj, S. P.
    Goudev, A.
    Huber, K.
    Cohen, A. -A.
    Jin, J.
    Merino, M.
    Winters, S. M.
    Goette, A.
    EUROPEAN HEART JOURNAL, 2018, 39 : 414 - 414
  • [22] Edoxaban was noninferior to warfarin for preventing stroke or systemic embolism in atrial fibrillation
    Johnson, Stacy A.
    Rondina, Matthew T.
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (06)
  • [23] COMPARISON OF MEDICAL COSTS AVOIDED AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH DABIGATRAN, RIVAROXABAN, APIXABAN, AND EDOXABAN VERSUS WARFARIN
    Amin, Alpesh N.
    Bruno, Amanda
    Trocio, Jeffrey
    Lin, Jay
    Lingohr-Smith, Melissa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1516 - A1516
  • [24] Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
    Alsultan, Mohammed M.
    Alahmari, Abdullah K.
    Mahmoud, Mansour A.
    Almalki, Ziyad S.
    Alzlaiq, Wafa
    Alqarni, Faisal
    Alsultan, Fahad
    Ahmed, Nehad Jaser
    Alenazi, Ahmed O.
    Scharf, Lucas
    Guo, Jeff Jianfei
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [25] Apixaban versus Warfarin in Atrial Fibrillation
    Vassiliou, Vassilios S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01): : 88 - 88
  • [26] Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
    Krejczy, Martin
    Harenberg, Job
    Wehling, Martin
    Obermann, Konrad
    Lip, Gregory Y. H.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [27] Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study
    Nielsen, P. B.
    Soegaard, M.
    Jensen, M.
    Ording, A. G.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2021, 42 : 288 - 288
  • [28] Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation
    O'Donoghue, Michelle L.
    Ruff, Christian T.
    Giugliano, Robert P.
    Murphy, Sabina A.
    Grip, Laura T.
    Mercuri, Michele F.
    Rutman, Howard
    Shi, Minggao
    Kania, Grzegorz
    Cermak, Ondrej
    Braunwald, Eugene
    Antman, Elliott M.
    EUROPEAN HEART JOURNAL, 2015, 36 (23) : 1470 - +
  • [29] Apixaban versus warfarin in patients with atrial fibrillation: examination of ARISTOTLE
    Szczerba, Ewa
    KARDIOLOGIA POLSKA, 2012, 70 (02) : 196 - 200
  • [30] NOACS VERSUS WARFARIN USE IN THE MANAGEMENT OF ATRIAL FIBRILLATION PATIENTS
    Biggs, Eleanor
    Allan, Victoria
    Vermes, Szabolcs
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 345 - 345
12345